Using a novel hypofractionated radiation schedule that effectively blocks prostate tumor growth in TRAMP mice, we show that blocking JNK signaling using a JNK1, 2 and 3 inhibitor (SP600125), counteracts the effects of therapeutic radiation and leads to tumor growth and progression, in a β1 integrin-dependent manner. This evidence concerns the gene MAPK8 and prostate neoplasm.